Four states petition the FDA to lift abortion pill restrictions
NBCJUN 6
TheThese FDAoutdated mustrestrictions thoroughlyare reviewmedically alarmingunjustified newbarriers. dataOne showingconservative mifepristonestudy, complicationswhich maywasn't bepeer 22reviewed, timesdoesn't highercancel thanout previouslythe reported.robus Insurancethe claimsevidence fromof the drugs' safety over 865,000the prescriptionspast reveal25 nearlyyears. 11%Rural ofand low-income women experiencesuffer potentiallymost life-threateningfrom complicationsthese withinrestrictions, 45but days.it's Currentobvious safetythis restrictionsis existpart forof goodthe reasonanti-abortion andmovement's protectplot womento fromend aabortion drugaccess thatno posesmatter seriouswhat risksit takes.
The FDA must thoroughly review alarming new data showing mifepristone complications may be 22 times higher than previously reported. Insurance claims from over 865,000 prescriptions reveal nearly 11% of women experience potentially life-threatening complications within 45 days. Current safety restrictions exist for good reason and protect women from a drug that poses serious risks.